Xianjun Xu
Overview
Explore the profile of Xianjun Xu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
124
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Mao T, Xu X, Liu L, Wu Y, Wu X, Niu W, et al.
J Transl Med
. 2024 Dec;
22(1):1119.
PMID: 39707364
Background: Yes-associated protein 1 (YAP1) regulates the survival, proliferation, and stemness of cells, and contributes to the development of metabolic dysfunction associated fatty liver disease (MAFLD). However, the regulatory role...
3.
Liu W, Yao Y, Wen J, Huang L, Chen S, Ogaji O, et al.
J Chromatogr A
. 2024 Dec;
1740:465597.
PMID: 39700610
A rapid and sensitive enrichment technique, field enhanced sample injection-dynamic pH junction-sweeping (FESI-DypH-sweeping) was successfully developed for the simultaneous separation and concentration of alkaloids and stereoisomers of Uncariae ramulus cum...
4.
Yan L, Xu X, Bao K
Anal Methods
. 2024 Sep;
16(36):6119-6133.
PMID: 39219454
Gallium metal and gallium compounds play significant roles in industry and medicine; however, their pollution and residue can pose potential risks to plants, animals and human health. Moreover, accurately detecting...
5.
Sun Z, Guo Y, Xu X, Zhou C, Luo X, Shen Z, et al.
J Gastroenterol Hepatol
. 2024 May;
39(8):1695-1703.
PMID: 38804845
Background And Aim: Hydronidone (HDD) is a novel pirfenidone derivative developed initially to reduce hepatotoxicity. Our previous studies in animals and humans have demonstrated that HDD treatment effectively attenuates liver...
6.
Xu X, Guo Y, Luo X, Shen Z, Sun Z, Shen B, et al.
Liver Int
. 2023 Aug;
43(11):2523-2537.
PMID: 37641479
Background And Purpose: Liver fibrosis is a wound-healing reaction that eventually leads to cirrhosis. Hydronidone is a new pyridine derivative with the potential to treat liver fibrosis. In this study,...
7.
Shen B, Gu T, Shen Z, Zhou C, Guo Y, Wang J, et al.
Cell Mol Gastroenterol Hepatol
. 2023 Aug;
16(6):857-879.
PMID: 37572735
Methods: The abundance of E coli was analyzed by using 16S ribosomal RNA sequencing in a cohort of patients with NAFLD and healthy controls. The role of E coli was...
8.
Zhou C, Shen Z, Shen B, Dai W, Sun Z, Guo Y, et al.
Biochim Biophys Acta Mol Basis Dis
. 2023 Jul;
1869(7):166810.
PMID: 37487374
Background And Aims: Non-alcoholic liver disease (NAFLD) is emerging as the leading cause of end-stage liver disease with a serious threat to global health burden. Fatty acid-binding protein 4 (FABP4)...
9.
Xu X, Zhong L, Feng H, Van der Eycken E
Chem Rec
. 2023 May;
23(10):e202300101.
PMID: 37132130
The highly efficient construction of complicated heterocyclic frameworks in an atom- and step-economic manner is still one of the cores of synthetic chemistry. Dearomatization reactions show the unique advantage for...
10.
Shen Z, Shen B, Dai W, Zhou C, Luo X, Guo Y, et al.
iScience
. 2023 May;
26(5):106572.
PMID: 37124414
Liver non-parenchymal cells (NPCs) play a critical role in the progression of non-alcoholic steatohepatitis (NASH). We aimed to explore the heterogeneity of NPCs and identify NASH-specific subpopulations contributing to NASH...